Table 6.
Enriched pathways for potential biomarkers.
| Pathway_name | Total | Hits | P value | -Log10(Pvalue) | FDR | Impact |
|---|---|---|---|---|---|---|
| Linoleic acid metabolism | 28 | 4 | 0.0009 | 3.0469 | 0.0395 | 0.2105 |
| Cholesterol metabolism | 10 | 2 | 0.0104 | 1.9830 | 0.1845 | 0.1111 |
| Choline metabolism in cancer | 11 | 2 | 0.0126 | 1.9003 | 0.1845 | 0.3258 |
| Pyrimidine metabolism | 65 | 3 | 0.0166 | 1.7794 | 0.3948 | 0.0386 |
| Synthesis and degradation of ketone bodies | 6 | 1 | 0.0497 | 1.3040 | 0.3948 | 0.1364 |
| Bile secretion | 97 | 5 | 0.0183 | 1.7378 | 0.2012 | 0.0459 |
| Glycine, serine and threonine metabolism | 50 | 3 | 0.0446 | 1.3503 | 0.3220 | 0.0093 |
| Taurine and hypotaurine metabolism | 22 | 2 | 0.0472 | 1.3256 | 0.3220 | 0.0882 |